Investor Presentaiton

Department of Health Notes to the financial statements For the year ended on 30 June 2023 10.1.3 Statement of Cash Flows Variances (continued) Variance Variance Notes Estimate between estimate and 2023 Actual 2023 Actual 2022 actual $'000 $'000 $'000 $'000 Variance between actual results for 2023 and 2022 $'000 CASH FLOWS FROM FINANCING ACTIVITIES Payments Principal element of lease payments Net cash used in financing activities Net increase/(decrease) in cash and cash equivalents Cash and cash equivalents at the beginning of the year (417) (764) (687) (347) (77) (417) (764) (687) (347) (77) 118 (63,685) 115,947 (63,803) (179,632) 252,126 252,127 136,180 1 115,947 CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD 252,244 188,442 252,127 (63,802) (63,685) < 206 Contents About us Significant issues Report on operations Agency performance ⚫Operational disclosures • Key performance indicators Financial disclosures and compliance • Appendix

View entire presentation